Plexus Corp. (PLXS) Q2 2025 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 29, 2025 (Fiscal Q2 2025) and the six months ended March 29, 2025. Plexus Corp. is a global manufacturer of complex products for the Aerospace/Defense, Healthcare/Life Sciences, and Industrial sectors. The company operates across three geographic segments: Americas (AMER), Asia-Pacific (APAC), and Europe, Middle East, and Africa (EMEA).
Key Financial Metrics
| Metric | Q2 2025 (3 Months) | Q2 2024 (3 Months) | YTD 2025 (6 Months) | YTD 2024 (6 Months) |
|---|---|---|---|---|
| Net Sales | $980.2 million | $966.9 million | $1,956.3 million | $1,949.5 million |
| Gross Profit | $97.8 million | $88.1 million | $198.4 million | $176.2 million |
| Gross Margin | 10.0% | 9.1% | 10.1% | 9.0% |
| Operating Income | $48.8 million | $29.5 million | $95.7 million | $74.6 million |
| Operating Margin | 5.0% | 3.0% | 4.9% | 3.8% |
| Net Income | $39.1 million | $16.2 million | $76.3 million | $45.5 million |
| Diluted EPS | $1.41 | $0.58 | $2.75 | $1.62 |
| Operating Cash Flow (YTD) | $90.3 million | |||
| Free Cash Flow (YTD) | $43.6 million | |||
| Cash & Equivalents | $310.6 million (as of Mar 29, 2025) | |||
| Total Debt | $209.8 million (as of Mar 29, 2025) |
Material Changes vs. Prior Period
- Profitability Surge: Net income increased 141% year-over-year for Q2 and 68% for the six-month period. This was driven by a 65% increase in operating income, primarily due to a $11.0 million reduction in restructuring charges compared to the prior year and improved gross margins.
- Margin Expansion: Gross margin improved by 90 basis points in Q2 and 110 basis points YTD, attributed to a positive shift in customer mix and operational efficiency initiatives reducing fixed costs.
- Segment Performance:
- APAC: Sales grew 12.5% (Q2) and 11.1% (YTD) driven by increased end-market demand and new product ramps.
- EMEA: Sales declined significantly, down 32.6% (Q2) and 25.5% (YTD), due to decreased customer end-market demand.
- AMER: Sales were relatively flat in Q2 (-0.3%) but declined 6.1% YTD due to customer disengagements, partially offset by new product ramps.
- Restructuring: The company incurred $4.7 million in restructuring costs YTD 2025 (severance in EMEA/AMER), compared to $11.0 million in the prior year period which included site closure costs.
- Interest Expense: Interest expense decreased significantly ($5.2 million in Q2, $9.2 million YTD) due to lower borrowings on the credit facility.
Guidance, Outlook, and Risks
- Capital Expenditures: Management estimates fiscal 2025 capital expenditures will be between $110.0 million and $130.0 million, including $60.0 million for a facility expansion in Penang, Malaysia.
- Tax Outlook: The annual effective tax rate for fiscal 2025 is expected to be approximately 13.0% to 15.0%.
- Liquidity: The company anticipates sufficient cash flows to meet requirements for the next 12 months. However, it expects to borrow under its Credit Facility to satisfy obligations when its $100 million Senior Notes mature in June 2025.
- Risks: Key risks include global economic conditions, supply chain constraints, component shortages, foreign currency fluctuations, and the impact of tariffs or trade disputes. The company notes that 77% of its cash is held outside the U.S.
Investor Verification Checklist
- Debt Maturity: Verify the refinancing strategy for the $100 million Senior Notes maturing in June 2025 and the current utilization of the Credit Facility.
- EMEA Demand: Assess the sustainability of the significant sales decline in the EMEA region and the impact of ongoing restructuring there.
- Customer Concentration: Review the impact of recent customer disengagements in the AMER and Aerospace/Defense sectors on future revenue visibility.
- Inventory Levels: Monitor inventory balances ($1.28 billion) relative to sales trends to ensure no future write-downs are required, especially given the reduction in inventory days.
- Share Repurchases: Confirm the remaining $25.0 million authority under the 2025 share repurchase program and the pace of future buybacks.